BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 32677981)

  • 1. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
    Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
    Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
    Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
    Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
    Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
    J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3β/β-catenin pathway in glioma.
    Chen Y; Xu H; Yu P; Wang Q; Li S; Ji F; Wu C; Lan Q
    CNS Neurosci Ther; 2023 Dec; 29(12):4124-4138. PubMed ID: 37408388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
    Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
    Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
    J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
    Bao Z; Chen L; Guo S
    J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E; Chen X; Xu Y; Ji X; Cheng M; Wang H; Fang Z; Zhao B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):366. PubMed ID: 31429770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11 Long noncoding RNA UCA1 functions as miR-135a sponge to promote the epithelial to mesenchymal transition in glioma.
    Li ZG; Xiang WC; Shui SF; Han XW; Guo D; Yan L
    J Cell Biochem; 2020 Mar; 121(3):2447-2457. PubMed ID: 31680311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
    Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
    J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
    Liu T; Hu J; Han B; Tan S; Jia W; Xin Y
    Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.